Methotrexate 10mg Tablets

Methotrexate 10mg is a folate-antagonist medicine used as a disease-modifying treatment for rheumatoid arthritis and severe psoriasis. Methotrexate is also used in specified cancer regimens, which have different schedules and monitoring requirements.
For rheumatoid arthritis or psoriasis, take the oral dose once weekly on the same named day, not daily. Cancer schedules differ and must not be inferred from the weekly autoimmune regimen. Swallow with water; food may help nausea. Folate supplementation follows a separate schedule.
Methotrexate interferes with folate-dependent cellular pathways. At low weekly doses it reduces inflammatory immune activity; in oncology it inhibits processes needed by rapidly dividing cells.
Nausea, mouth ulcers, fatigue, reduced blood counts and raised liver enzymes can occur. Fever, unusual bleeding, severe mouth ulceration, dry cough or new breathlessness needs urgent assessment.
Daily use in place of a weekly autoimmune dose can be fatal. Blood counts, liver and kidney tests are essential. Pregnancy must be avoided. Trimethoprim or co-trimoxazole can greatly increase marrow toxicity. Dehydration and renal impairment can increase exposure.
Can reduce inflammatory disease activity and joint damage progression in rheumatoid arthritis or control severe psoriasis when systemic treatment is needed.
No. Low-dose methotrexate for arthritis or psoriasis is taken once weekly. Taking that weekly dose daily is a dangerous medication error.
Folate supplementation can reduce some gastrointestinal, mouth and liver adverse effects; it has its own treatment schedule.
Disease-modifying benefit develops over weeks rather than immediate pain relief, and the full response can take longer.
Trimethoprim and co-trimoxazole can markedly increase bone-marrow toxicity and are particularly important interactions.
Seek urgent medical advice immediately, even without symptoms. Serious marrow and mucosal toxicity can be delayed.
Yes. Infection symptoms, unusual bruising and persistent mouth ulcers are important warning signs during treatment.
DMARD: disease-modifying antirheumatic drug. Folate antagonist: a medicine interfering with folate-dependent pathways. Myelosuppression: reduced bone-marrow blood-cell production. Weekly dosing: administration on one designated day each week; AR: Methotrexate 10mg أقراص; FR: Methotrexate 10mg comprimés; PT: Methotrexate 10mg comprimidos; ES: Methotrexate 10mg comprimidos; RU: Methotrexate 10mg таблетки; ID: Methotrexate 10mg tablet; VI: Methotrexate 10mg viên nén; MS: Methotrexate 10mg tablet; TL: Methotrexate 10mg tableta; ZH-SG: Methotrexate 10mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Methotrexate 10mg Tablets under Immunology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Methotrexate 10mg Tablets